Status:
COMPLETED
Interaction Between Tramadol and Ondansetron
Lead Sponsor:
Acibadem University
Conditions:
Cholecystectomy, Laparoscopic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In the postoperative period; pain, nausea, and vomiting are undesirable side effects that reduce the patient's comfort and may lead to various complications. Ondansetron is frequently used as an antie...
Detailed Description
During the operation, 4 mg iv ondansetron (2mL) will be administered to the ondansetron group and 2mL iv 09% saline will be administered to the placebo group. The patients' heart rate, blood pressure,...
Eligibility Criteria
Inclusion
- 60 patients over the age of 18, ASA I-II, undergoing laparoscopic cholecystectomy
Exclusion
- Patients under 18 years of age
- Patients with known allergies to the drugs to be used
- Pregnant and breastfeeding mothers
- Patients who received antiemetic or cortisone within 24 hours before surgery
- Patients with mental illness or epilepsy
- Patients with alcohol or substance abuse
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04745273
Start Date
September 2 2020
End Date
June 25 2021
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem Kozyatagi Hastanesi
Istanbul, Turkey (Türkiye), (_34742__) ______